Size estimation of groups at high risk of HIV/AIDS using network scale up in Kerman, Iran

International Journal of Preventive Medicine

Volumn 3, Issue 7, 2012, Pages 471-476

  Shokoohi, Mostafa ^a,b   Baneshi, Mohammad Reza ^c,d   Haghdoost, Ali Akbar ^b,c,d  

^a KERMAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b KERMAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c KERMAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d KERMAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

HIV; Iran; Most at risk population; Network scale up

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; OPIATE;

ADULT; ALCOHOL CONSUMPTION; ARTICLE; COITUS; CONTROLLED STUDY; FEMALE; HEALTH PROGRAM; HIGH RISK BEHAVIOR; HIGH RISK POPULATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION CONTROL; INFECTION RISK; INTRAVENOUS DRUG ABUSE; IRAN; MAJOR CLINICAL STUDY; MALE; MALE HOMOSEXUAL; POPULATION SIZE; PROBABILITY; PROSTITUTION; RISK ASSESSMENT; SENSITIVITY ANALYSIS; VIRUS TRANSMISSION;

EID: 84864057384     PISSN: 20087802     EISSN: 20088213     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. UNAIDS, World AIDS epidemic update: November2009. Geneva: The Joint UnitedNations Programme on HIV/AIDS and the World Health Organization (2009).
2. Estimation of the size of high risk groups and HIV prevalence in high risk groups in concentrated epidemics. Proceedings of the UNAIDS Reference Group on Estimates; 2008Dec9-10; Amsterdam, Netherlands; 2008.
3. Fallahzadeh H, Morowatisharifabad M, Ehrampoosh MH. HIV/AIDS Epidemic Features and Trends in Iran, 1986-2006. AIDS Behav 2009;13:297-302.
4. Ramezani A, Mohraz M, Gachkar L. Epidemiologic situation of human immunodeficiency virus (HIV/AIDS patients) in a private clinic in Tehran, Iran. Arch Iran Med 2006;9:315-8.
5. UNODC, World Drug Report 2006, vol2, Sect. 6.2.
6. Ohiri K, Claeson M, Rassaghi E, Nassirimanesh B, Afshar P, Power R. HIV/AIDS Prevention among Injection Drug Users: Learning from Harm Reduction in Iran. Iran: HIV Prevention Consultation; April17-20. 2006.
7. Eshrati B, Asl RT, Dell CA, Afshar P, Millson PM, Kamali M, et al. Preventing HIV transmission among Iranian prisoners: initial support for providing education on the benefits of harm reduction practices. Harm Reduct J 2008;5:21.
8. Razani N, Mohraz M, Khairandish P, Malekinejad M, Malekafzali H, Mokri A, et al. HIV risk behavior among injection drug users in Tehran, Iran. Addiction 2007;102:1472-82.
9. Nassirimanesh B, Trace M, Roberts M. The rise of harm reduction in the Islamic Republic of Iran. Briefing Paper Eight, for the Beckley Foundation, Drug Policy Program, 2005.
10. Mojtahedzadeh V, Razani N, Malekinejad M, VazirianM, Shoaee S, Saberi Zafarghandi MB, et al. Injection drug use in rural Iran: Integrating HIV prevention into Iran's rural primary health care system: Springer, 2008. p. 7-12.
11. Zamani S, Vazirian M, Nassirimanesh B, Razzaghi E, Ono-Kihara M, Mortazavi Ravari S, et al. Needle and Syringe Sharing Practices Among Injecting Drug Users in Tehran: AComparison of Two Neighborhoods, One with and One Without a Needle and Syringe Program. AIDS Behav 2010;14:885-90.
12. UNAIDS. Estimating the size of populations at risk for HIV. San Francisco: Family Health International; 2002.
13. Zamani S. Integrated biobehavioral surveillance among injecting drug users in Iran in 2007, MOHME, Ministry of Health and Medical Education, Center of Diseases Management, Sexually Transmitted Disease and AIDS Office (Unpublished data).
14. Navadeh S, Mirzazadeh A, Haghdoost A, Sedaghat A, Gouya MM, Arabnejad S. Integrated biobehavioral surveillance among prisoners in Iran in 2009, MOHME, Ministry of Health and Medical Education, Center of Diseases Management, Sexually Transmitted Disease and AIDS Office, (Unpublished data).
15. MOHME, Ministry of Health and Medical Education, Center of Diseases Management, Sexually Transmitted Disease and AIDS Office. Statistics of sentinel site surveys. January2010, (Unpublished data).
16. Ilami O, Sarkari B, Khosravani A, Tori MA, Hosseini Z. HIV Seroprevalence among high-risk groups in Kohgiloyeh and Boyerahmad Province, Southwest of Iran, a behavioral surveillance survey. AIDS Behav 2012;16:86-90.
17. MOHME, Ministry of Health and Medical Education, Center of Diseases Management, Sexually Transmitted Disease and AIDS Office. Report of monitoring and evaluation of the second national strategic plan to control HIV/AIDS(2007-2009). March2010.
18. Magnani R, Sabin K, Saidel T, HeckathornDD. Review of sampling hard-to-reach and hidden populations for HIV surveillance. AIDS 2005;19(Suppl 2):S67-72.
19. UNAIDS, IMPACT, FHI. Estimating the Size of Populations at Risk for HIV [Online]. Jul 2003; Available from: http://www.data.unaids.org/publications/ExternalDocuments/estimatingpopsizes_en.pdf/ [Last accessed on 2011 Sept 20].
20. Vadivoo S, Gupte MD, Adhikary R, Kohli A, KangusamyB, Joshua V, et al. Appropriateness and execution challenges of three formal size estimation methods for high-risk populations in India. AIDS2008;22(Suppl5):S137-48.
21. Estimating the Size of Populations at Risk for HIV: Issues and Methods, Updated July2003, UNAIDS/WHO working group on HIV/AIDS/STI surveillance.
22. Hook EB, Regal RR. Capture-recapture methods in epidemiology: Methods and limitations. Epidemiol Rev 1995;17:243-64.
23. Khan SI, Bhuiya A, Uddin AS. Application of the capture-recapture method for estimating number of mobile male sex workers in a port city of Bangladesh. J Health Popul Nutr 2004;22:19-26.
24. Zhang D, Wang L, Lv F, Su W, Liu Y, Shen R, et al. Advantages and challenges of using census and multiplier methods to estimate the number of female sex workers in a Chinese city. AIDS Care 2007;19:17-9.
25. Killworth PD, Johnsen EC, McCarty C, Shelley GA, Bernard HR. Asocial network approach to estimating seroprevalence in the United States. Soc Networks 1998;20:23-50.
26. Killworth PD, McCarty C, Bernard HR, Shelley GA, Johnsen EC. Estimation of Seroprevalence, Rape, and Homelessness in the United States Using a Social Network Approach. Eval Rev 1998;22:289-308.
27. Killworth PD, Johnsen EC, Bernard HR, Shelley GA, McCarty C. Estimating the size of personal networks. Soc Networks 1990;12:289-312.
28. Snidero S, Corradetti R, Gregori D. The Network Scale-Up Method: ASimulation Study in Case of Overlapping Sub-Populations. Metodolǒski zvezki 2004;1:395-405.
29. Shokoohi M, Baneshi MR, Haghdoost AA. Estimation of the active network size of Kermanian Males. J Addict Health 2010;2:81-7.
30. Gheiratmand R, Navipour R, Mohebbi MR, Mallik AK. Uncertainty on the number of HIV/AIDS patients: our experience in Iran. Sex Transm Infect 2005;81:279-80.
31. Ziaaddini H, Ziaaddini MR. The Household Survey of Drug Abuse in Kerman, Iran. JAppl Sci 2005;5:380-2.
32. Nakhaee N, Ziaaddini H, Karimzadeh A. Epidemiologic Study on Drug Abuse among First and Second Grade High School Students in Kerman. JAddict Health 2009;1:31-6.
33. Mohammadpour Asl A, Fakhari A, Rostami F, Gholivahidi R, Dastgiri S. Epidemiologic Study on Alcohol and Ecstasy Drugs Abuse among Second Grade High School Students in Tabriz. JArdabil Univ Med Sci 2006;7:400-8.
34. Hamdieh M, Motalebi N, Asheri H, Boroujerdi A. Prevalence of Alcohol and Drug Abuse in Young People, 15-35 Year Old, Living in Tehran, Iran. Pejouhesh 2008;32:315-9.